These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2150950)

  • 1. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity.
    Newman RH; Freemont PS; Barton GJ; Crumpton MJ
    Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
    Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
    Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
    Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
    Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
    Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
    Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
    Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
    Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural homology between uteroglobin and the pore-forming domain of colicin A suggests a possible mechanism of action for uteroglobin.
    de la Cruz X; Lee B
    Protein Sci; 1996 May; 5(5):857-61. PubMed ID: 8732757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the putative PLA2-inhibiting sequence of annexin 1.
    Travé G; Lees D; Liautard JP; Widada JS
    FEBS Lett; 1991 Nov; 293(1-2):34-6. PubMed ID: 1835701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A series of annexins from human placenta and their characterization by use of an endogenous phospholipase A2.
    Buhl WJ; García MT; Zipfel M; Schiebler W; Gehring U
    Eur J Cell Biol; 1991 Dec; 56(2):381-90. PubMed ID: 1839383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel peptides derived from a region of local homology between uteroglobin and lipocortin-1 inhibit platelet aggregation and secretion.
    Vostal JG; Mukherjee AB; Miele L; Shulman NR
    Biochem Biophys Res Commun; 1989 Nov; 165(1):27-36. PubMed ID: 2531581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins).
    Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M
    Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of bombolitin III with phospholipid monolayers and liposomes and effect on the activity of phospholipase A2.
    Signor G; Mammi S; Peggion E; Ringsdorf H; Wagenknecht A
    Biochemistry; 1994 May; 33(21):6659-70. PubMed ID: 8204603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
    Lloret S; Moreno JJ
    Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocortin-like anti-phospholipase A2 activity of endonexin.
    Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
    FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
    van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
    FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common domain structure of Ca2+ and lipid-binding proteins.
    Geisow MJ
    FEBS Lett; 1986 Jul; 203(1):99-103. PubMed ID: 2941317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A2 and lipocortin effects.
    Dennis EA; Davidson FF
    Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
    [No Abstract]   [Full Text] [Related]  

  • 20. Uteroglobin inhibits phospholipase A2 activity.
    Levin SW; Butler JD; Schumacher UK; Wightman PD; Mukherjee AB
    Life Sci; 1986 May; 38(20):1813-9. PubMed ID: 3084897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.